A detailed history of Penserra Capital Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 25,063 shares of RYTM stock, worth $1.51 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,063
Holding current value
$1.51 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.81 - $55.0 $1.02 Million - $1.38 Million
25,063 New
25,063 $1.31 Million
Q4 2021

Feb 15, 2022

SELL
$8.62 - $13.9 $9,869 - $15,915
-1,145 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$18.52 - $22.55 $648 - $789
35 Added 3.15%
1,145 $22,000
Q1 2021

May 13, 2021

BUY
$20.25 - $39.49 $1,923 - $3,751
95 Added 9.36%
1,110 $23,000
Q4 2020

Feb 12, 2021

BUY
$21.17 - $32.61 $13,485 - $20,772
637 Added 168.52%
1,015 $30,000
Q3 2020

Nov 13, 2020

BUY
$18.13 - $30.61 $6,853 - $11,570
378 New
378 $8,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.35B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.